LONG-TERM FOLLOW-UP OF PATIENTS WITH ADVANCED PROSTATIC-CARCINOMA TREATED WITH EITHER BUSERELIN (HOE 766) OR ORCHIECTOMY - CLASSIFICATION OF VARIABLES ASSOCIATED WITH DISEASE OUTCOME

被引：35

作者：

KOUTSILIERIS, M ^{[1
]}

TOLIS, G ^{[1
]}

机构：

[1] HIPPOKRATEION HOSP, DIV ENDOCRINOL, ATHENS, GREECE

来源：

PROSTATE | 1985年 / 7卷 / 01期

关键词：

D O I：

10.1002/pros.2990070105

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：31 / 39

页数：9

共 14 条

[1] SUSTAINED SUPPRESSION OF TESTOSTERONE PRODUCTION BY THE LUTEINIZING-HORMONE RELEASING-HORMONE AGONIST BUSERELIN IN PATIENTS WITH ADVANCED PROSTATE CARCINOMA - A NEW THERAPEUTIC APPROACH [J].

BORGMANN, V ;

HARDT, W ;

SCHMIDTGOLLWITZER, M ;

ADENAUER, H ;

NAGEL, R .

LANCET, 1982, 1 (8281) :1097-1099

[2] PRELIMINARY-RESULTS ON THE CLINICAL EFFICACY AND SAFETY OF ANDROGEN INHIBITION BY AN LHRH AGONIST ALONE OR COMBINED WITH AN ANTI-ANDROGEN IN THE TREATMENT OF PROSTATIC-CARCINOMA [J].

FAURE, N ;

LEMAY, A ;

LAROCHE, B ;

ROBERT, G ;

PLANTE, R ;

JEAN, C ;

THABET, M ;

ROY, R ;

FAZEKAS, ATA .

PROSTATE, 1983, 4 (06) :601-624

[3] GONADOTROPIN-RELEASING HORMONE AGONISTIC ANALOGS IN THE TREATMENT OF ADVANCED PROSTATIC-CARCINOMA [J].

KOUTSILIERIS, M ;

TOLIS, G .

PROSTATE, 1983, 4 (06) :569-577

[4]

KOUTSILIERIS M, 1984, SATELLITE S LHRH ITS

[5]

KOUTSILIERIS M, 1984, 7TH INT C END QUEB C

[6] NEW APPROACH IN THE TREATMENT OF PROSTATE-CANCER - COMPLETE INSTEAD OF PARTIAL WITHDRAWAL OF ANDROGENS [J].

LABRIE, F ;

DUPONT, A ;

BELANGER, A ;

LACOURSIERE, Y ;

RAYNAUD, JP ;

HUSSON, JM ;

GAREAU, J ;

FAZEKAS, ATA ;

SANDOW, J ;

MONFETTE, G ;

GIRARD, JG ;

EMOND, J ;

HOULE, JG .

PROSTATE, 1983, 4 (06) :579-594

[7] LONG-TERM EFFECTS OF ADMINISTRATION OF A GONADOTROPIN-RELEASING HORMONE SUPERAGONIST ANALOG IN MEN WITH PROSTATIC-CARCINOMA [J].

SANTEN, RJ ;

DEMERS, LM ;

MAX, DT ;

SMITH, J ;

STEIN, BS ;

GLODE, LM .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 58 (02) :397-400

[8]

SCHALLY AV, EXCERPTA MED SER 652, V2255

[9] SUPPRESSION OF TESTICULAR STEROIDOGENESIS BY THE GNRH AGONISTIC ANALOG BUSERELIN (HOE-766) IN PATIENTS WITH PROSTATIC-CANCER - STUDIES IN RELATION TO DOSE AND ROUTE OF ADMINISTRATION [J].

TOLIS, G ;

FAURE, N ;

KOUTSILIERIS, M ;

LEMAY, A ;

KLIOZE, S ;

YAKABOW, A ;

FAZEKAS, ATA .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1983, 19 (01) :995-998

[10] TUMOR-GROWTH INHIBITION IN PATIENTS WITH PROSTATIC-CARCINOMA TREATED WITH LUTEINIZING-HORMONE-RELEASING HORMONE AGONISTS [J].

TOLIS, G ;

ACKMAN, D ;

STELLOS, A ;

MEHTA, A ;

LABRIE, F ;

FAZEKAS, ATA ;

COMARUSCHALLY, AM ;

SCHALLY, AV .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (05) :1658-1662

← 1 2 →